Goggle technique effective in measuring oxygen consumption

Article

A technique using a goggle with an oxygen sensitive material on the inner surface has been demonstrated to be a successful non-contact method for assessing oxygen uptake of the whole anterior eye

A technique using a goggle with an oxygen sensitive material on the inner surface has been demonstrated to be a successful non-contact method for assessing oxygen uptake of the whole anterior eye, in a recent study published in Contact Lens & Anterior Eye.

A team led by Dr Shehzad A. Naroo et al., Life and Health Sciences, Ophthalmic Research Group, Aston University, Birmingham, UK, studied the oxygen depletion of the unrestricted eyes of 10 patients.

Each measurement was conducted over a 3-minute period using a goggle with oxygen sensitive material contained in the inner surface. The goggle was positioned on the eye and the volume in the goggle and bone structure was recorded by water volume displacement and the output corrected to O2% reduction/cm³. Measurements were taken in both open and closed–eye conditions.

The results demonstrated that the mean oxygen depletion during open eye state was 3.10 ± 1.51 O2% cm³. Using the goggle proved to be a non-invasive, non-contact technique for the measurement of oxygen consumption.

Recent Videos
Patrick C. Staropoli, MD, discusses clinical characterisation of Hexokinase 1 (HK1) mutations causing autosomal dominant pericentral retinitis pigmentosa
Richard B. Rosen, MD, discusses his ASRS presentation on illuminating subclinical sickle cell activities using dynamic OCT angiography
ASRS 2024: Socioeconomic barriers and visual outcomes in patients with rhegmatogenous retinal detachments, from Sally S. Ong, MD
Ashkan Abbey, MD, speaks about his presentation on the the CALM registry study, the 36-month outcomes of real world patients receiving fluocinolone acetonide 0.18 mg at the annual ASRS meeting in Stockholm, Sweden.
Nikoloz Labauri, MD, FVRS, speaks at the 2024 ASRS meeting about suspensory macular buckling as a novel technique for addressing myopic traction maculopathy
Jordana Fein, MD, MS, speaks with Modern Retina about the IOP outcomes with aflibercept 8 mg and 2 mg in patients with DME through week 48 of the phase 2/3 PHOTON trial at the annual ASRS meeting in Stockholm, Sweden.
John T. Thompson, MD, discusses his presentation at ASRS, Long-Term Results of Macular Hole Surgery With Long-Acting Gas Tamponade and Internal Limiting Membrane Peeling
ASRS 2024: Michael Singer, MD, shares 100-week results from the RESTORE trial
© 2024 MJH Life Sciences

All rights reserved.